Sentien Biotechnologies, Inc. Employee Directory
BiotechnologyUnited States11-50 Employees
Sentien Biotechnologies, Inc. is a United States–based clinical-stage biotechnology company pursuing novel cell-therapy approaches with specialized delivery concepts. Its lead product seeks to deliver mesenchymal stem cell–secreted factors in a controlled, sustained manner by immobilizing the cells in an extracorporeal device, enabling doses not achievable with direct injections. This approach aims to address a broad set of acute inflammatory diseases by providing regulated exposure to therapeutic MSC-derived factors. The company operates in the biotechnology research arena, with a focus on advancing cell therapy through innovative delivery systems. Its target customers are researchers and developers pursuing cell-based therapies, including clinical teams seeking durable factor delivery to modulate inflammation. In 2020, Sentien announced partnerships with RoosterBio and GenCure to advance MSC-based collaboration in contract development efforts.